G6PD and breast carcinoma: In this study, we also identified an abnormally elevated expression of G6PD protein in primary breast carcinoma tissues with a positive follow-up of metastasis compared with corresponding recurrent metastases and primary breast carcinoma tissues with no evidence of recurrence or metastasis during follow-up, suggesting that G6PD overexpression might be responsible for cancer recurrent metastases.